Outpatient Treatment of Low-risk Pulmonary Embolism
| Status: | Completed |
|---|---|
| Conditions: | Cardiology, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/1/2018 |
| Start Date: | December 2012 |
| End Date: | December 2017 |
Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism
This study is looking at the safety and effectiveness of treating Patients diagnosed with a
low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient
hospitalization. Patients have several medical tests done during their Emergency Department
visit. Based on those tests, those who are determined to have a low-risk PE are eligible to
participate in the study. Those choosing to participate are discharged after 12 hours of
medical observation. Patients who choose to participate are followed up by telephone
approximately 90 days later.
low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient
hospitalization. Patients have several medical tests done during their Emergency Department
visit. Based on those tests, those who are determined to have a low-risk PE are eligible to
participate in the study. Those choosing to participate are discharged after 12 hours of
medical observation. Patients who choose to participate are followed up by telephone
approximately 90 days later.
Inclusion Criteria:
1. Pulmonary Embolism, diagnosed by CTA or high probability VQ Scan
2. Total Pulmonary Embolism Severity Index (PESI) score <86
Exclusion Criteria:
1. Massive Pulmonary Embolism: Hypotension with signs of right heart strain on CTA or
Echocardiogram
2. Sustained Systolic Blood Pressure (SBP) <95 mmHg during Emergency Department or
observation stay.
3. Age <18
4. Pregnant
5. Renal insufficiency (Creatinine Clearance <30)
6. Hepatic Dysfunction (AST/ALT/ALP > 3 times upper limit of normal)
7. Unreliable social situation or inability to follow up
8. Contraindication to enoxaparin, warfarin and rivaroxaban
9. Atrial or ventricular dysrhythmia(s)
We found this trial at
1
site
5121 S Cottonwood St
Murray, Utah 84157
Murray, Utah 84157
(801) 507-7000
Principal Investigator: Joseph Bledsoe, MD
Phone: 801-507-4791
Intermountain Medical Center Intermountain Medical Center is one of the most technologically advanced and patient-friendly...
Click here to add this to my saved trials
